AXA S.A. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$4,285,541
+8.6%
76,574
+0.4%
0.01%
+14.3%
Q2 2022$3,946,246
-30.1%
76,246
-1.9%
0.01%
-12.5%
Q1 2022$5,648,247
+22.9%
77,728
+100.0%
0.01%
-33.3%
Q4 2021$4,595,000
-10.8%
38,864
+1.2%
0.01%
-14.3%
Q3 2021$5,151,000
-57.0%
38,401
-48.1%
0.01%
-17.6%
Q2 2021$11,976,00073,9720.02%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders